Private equity investors are showing increased interest in the cardiology space. Why? Likely several reasons. The United States is aging, and becoming more obese, and the need for cardiologists will increase as a result. This increase in demand is likely to outstrip the number of cardiologists practicing in the United States given a looming shortage of those specialists. In addition, cardiology practices still drive high margin procedures and are well-suited to leverage revenue generators such as nuclear medicine, ultrasound, and office-based labs (OBLs) and ambulatory surgery centers (ASCs), especially as the Centers for Medicare & Medicaid Services (CMS) releases more procedures that can be performed in an ambulatory setting.
Read the full article: Cardiology: The New Darling of Private Equity Investment //
Source: https://www.foley.com/en/insights/publications/2023/02/cardiology-new-darling-private-equity-investment